|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 03/22/23
- Coinbase says 'we are confident in the legality of our assets and services'
- 03/22/23
- Coinbase falls 7% to $71.70 after announcing Wells Notice from SEC
- 03/22/23
- Coinbase receives Wells Notice from SEC
- 03/21/23
- Cathie Wood's ARK Investment sold 161K shares of Coinbase today
- 07:07 Today
- Ford backs FY23 adjusted EBIT view $9B-$11B
- 07:04 Today
- Ford to report financial results based on three new global business segments
- 03/21/23
- Ford selects John Dion to be chief transformation officer
- 03/21/23
- EU passenger car registrations up 11.5% in February
- 07:05 Today
- Darden reports Q3 blended same-restaurant sales increase of 11.7%
- 03/19/23
- Fly Intel: Top five weekend stock stories
- 12/16/22
- Darden reports Q2 blended same-restaurant sales increase of 7.3%
- 12:00 Today
- Block falls -13.2%
- 10:00 Today
- Block falls -19.4%
- 09:47 Today
- Block falls -19.9%
- 08:55 Today
- Block extends decline to 20% after Hindenburg Research short report
- 01/11/23
- ICL signs strategic partnership agreement with General Mills
- 12/05/22
- IHOP and General Mills partner to turn the brand's iconic pancakes into cereal
- 11/14/22
- General Mills director Cordani sells 26,100 common shares
- 10/03/22
- General Mills exec sells $2.0M in common stock
- 02/16/23
- Accolade announces Michael Hilton to join board of directors
- 02/06/23
- Cathie Wood's ARK Investment bought 313.7K shares of Accolade today
- 09:47 Today
- Chewy falls -5.7%
- 03/22/23
- Chewy says closing two oldest non-automated fulfillment centers
- 12/08/22
- Chewy says now expects FY22 capex to come in slightly below 2.5% of sales
- 10/20/22
- Chewy expands CarePlus with new plan by Lemonade Pet
- 03/03/23
- Samsara rises 21.2%
- 03/03/23
- Samsara rises 13.3%
- 03/02/23
- Samsara says Q1 will be lowest quarter of the year on net new ARR
- 12/02/22
- Samsara rises 21.9%
- 12/05/22
- BellRing Brands announces new $50M share repurchase plan
- 11/22/22
- Post Holdings to exit ownership of BellRing Brands
- 03/14/23
- Senate Democrats urge Walmart, Kroger, others to sell mifepristone
- 03/02/23
- Walmart to open 28 new Walmart Health center locations in 2024
- 02/28/23
- Citi, Walmart introduce the Bridge built by Citi platform to Walmart suppliers
- 02/28/23
- Walmart, CareSource enter agreement to address health disparities
- 03/20/23
- Charles Schwab director buys $200K in common stock
- 03/17/23
- Charles Schwab reports $16.5B in core net new assets over past five trading days
- 03/16/23
- Charles Schwab director buys $233.5K in common stock
- 03/15/23
- Charles Schwab director buys $2.0M in common stock
- 02/22/23
- Texas Pacific Land, bpx energy reach long-term agreement
- 02/16/23
- BP Products North America to acquire TravelCenters of America for $1.3B in cash
- 02/15/23
- Hertz, BP to build national network of EV fast charging infrastructure
- 02/15/23
- White House announces progress for national network of EV chargers
- 03/20/23
- Starbucks announces Laxman Narasimhan assumes role of CEO
- 03/01/23
- Senator Sanders announces HELP panel vote on Starbucks CEO subpoena
- 02/23/23
- Starbucks introduces Starbucks Oleato coffee, olive oil beverages
- 02/20/23
- PepsiCo recalling Starbucks vanilla Frappuccino bottles
- 03/21/23
- EU passenger car registrations up 11.5% in February
- 03/20/23
- Moody's upgrades Tesla's credit rating, declares outlook stable
- 03/14/23
- Cathie Wood's ARK Investment bought 2.6K shares of Tesla today
- 03/13/23
- Cathie Wood's ARK Investment bought 26.7K shares of Tesla today
- 05:16 Today
- Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints
- 03/22/23
- Regeneron announces FDA approval of Evkeeza for young children
- 03/21/23
- Regeneron, Sanofi announce EC approval of Dupixent
- 03/19/23
- Regeneron, Sanofi present results from Dupixent clinical trial
- 05:16 Today
- Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints
- 03/21/23
- Regeneron, Sanofi announce EC approval of Dupixent
- 03/19/23
- Regeneron, Sanofi present results from Dupixent clinical trial
- 03/18/23
- Sanofi says moderate-to-severe atopic hand, foot dermatitis trial met endpoints
- 12:00 Today
- On Holding rises 12.9%
- 03/21/23
- On Holding rises 28.1%
- 03/21/23
- On Holding rises 24.1%
- 03/21/23
- On Holding rises 22.9%
- 08:41 Today
- Trupanion announces CFO Wolff to step down, Li to serve as interim CFO
- 01/10/23
- Trupanion announces proposal to eliminate staggered board
- 01/10/23
- Trupanion CEO to assume additional role as chair of the board
- 11/10/22
- Aflac, Trupanion announce joint venture in Japan
- 11:09 Today
- Uranium Energy slides as Kerrisdale says short shares, calls miner 'radioactive'
- 01/25/23
- Uranium Energy receives $17.85M from DOE
- 12/20/22
- Uranium Energy awarded contract from U.S. DOE
- 10/12/22
- Uranium Energy to acquire Rio Tinto Roughrider uranium development project
- 03/14/23
- SPDR Regional Banking ETF KRE jumps 9% at the open
- 03/14/23
- Comerica trading resumes
- 03/14/23
- Comerica trading halted, volatility trading pause
- 03/13/23
- Comerica trading resumes
- 07:53 Today
- Accenture expected to cut 19,000 people, or 2.5% of current workforce
- 07:43 Today
- Accenture says initiated actions to streamline operations in Q2
- 06:53 Today
- Accenture reports Q2 new bookings $22.1B
- 06:50 Today
- Accenture declares quarterly dividend of $1.12 per share, up 15% y/y
- 10:00 Today
- Steelcase rises 14.1%
- 09:47 Today
- Steelcase rises 13.5%
- 03/22/23
- Steelcase spikes 13% higher after reporting quarterly results and guidance
- 10/20/22
- Steelcase appoints Gupta to board of directors
- 03/22/23
- KB Home sees Q2 average selling price of about $480K
- 03/22/23
- KB Home sees Q2 housing revenue at $1.35B-$1.50B
- 03/22/23
- KB Home says labor costs proving to be sticky
- 03/22/23
- KB Home says encouraged with recent order trends
- 07:06 Today
- FactSet expects to resume share repurchase program in Q3, Q4
- 01/26/23
- BMO Wealth Management selects FactSet as market data provider
- 01/11/23
- FactSet, Coin Metrics collaborate for digital asset data, analytics
- 12/20/22
- FactSet not planning to resume buybacks until at least Q3
- 08:30 Today BofA
- SEC action to weigh on Coinbase shares, says BofA
- 07:22 Today Jefferies
- Coinbase Wells notice likely precursor to enforcement action, says Jefferies
- 07:06 Today Mizuho
- Wells Notice 'significant overhang' on Coinbase shares, says Mizuho
- 06:57 Today JPMorgan
- Coinbase regulatory risk is meaningful, says JPMorgan
- 03/21/23 Morgan Stanley
- EV price cuts 'not a fad, but a trend,' says Morgan Stanley
- 02/15/23 Tudor Pickering
- Ford downgraded to Hold from Buy at Tudor Pickering
- 02/14/23 Barclays
- Barclays starts autos and mobility sector, says Tesla stands out
- 02/14/23 Barclays
- Ford initiated with an Equal Weight at Barclays
- 03/13/23 Wedbush
- Darden price target raised to $165 from $160 at Wedbush
- 03/10/23 Stifel
- Darden price target raised to $160 from $150 at Stifel
- 02/02/23 Guggenheim
- Guggenheim sees Darden as among 'best managed,' starts with a Buy
- 02/02/23 Guggenheim
- Darden initiated with a Buy at Guggenheim
- 12:02 Today RBC Capital
- RBC Capital issues initial thoughts on Block short report
- 11:54 Today KeyBanc
- KeyBanc sees 'no merit' to disparaging claims made against Block by short seller
- 11:02 Today Raymond James
- Block short report doesn't include 'bombshell,' says Raymond James
- 10:55 Today Mizuho
- Block short report makes some valid arguments, says Mizuho
- 03/20/23 Deutsche Bank
- General Mills price target lowered to $84 from $88 at Deutsche Bank
- 02/22/23 Stifel
- General Mills price target raised to $84 from $82 at Stifel
- 02/01/23 Stifel
- Stifel not surprised by potential competitive entrant from Blue Buffalo
- 02/01/23 Mizuho
- General Mills initiated with a Neutral at Mizuho
- 06:41 Today Guggenheim
- Accolade upgraded at Guggenheim after benefits survey, management meetings
- 06:16 Today Guggenheim
- Accolade upgraded to Buy from Neutral at Guggenheim
- 02/09/23 Jefferies
- Accolade downgraded to Hold at Jefferies after 'lukewarm' survey results
- 02/09/23 Jefferies
- Accolade downgraded to Hold from Buy at Jefferies
- 10:43 Today Evercore ISI
- Chewy price target lowered to $53 from $55 at Evercore ISI
- 07:53 Today Morgan Stanley
- PetMed Express price target lowered to $17 from $18 at Morgan Stanley
- 06:30 Today Deutsche Bank
- Chewy downgraded to Hold from Buy at Deutsche Bank
- 05:33 Today Barclays
- Chewy price target lowered to $33 from $35 at Barclays
- 04:58 Today Morgan Stanley
- Samsara downgraded to Equal Weight from Overweight at Morgan Stanley
- 03/16/23 Piper Sandler
- Piper starts Samsara at Neutral with valuation not compelling
- 03/15/23 Piper Sandler
- Samsara initiated with a Neutral at Piper Sandler
- 03/03/23 Goldman Sachs
- Samsara upgraded to Buy at Goldman ahead of free cash flow inflection
- 08:37 Today Truist
- Truist upgrades BellRing Brands to Buy with removed overhang of Post Holdings
- 06:13 Today Truist
- BellRing Brands upgraded to Buy from Hold at Truist
- 02/09/23 Bernstein
- Bernstein ponders takeover targets for J.M. Smucker after pet food sale
- 02/08/23 Morgan Stanley
- BellRing Brands price target raised to $32 from $30 at Morgan Stanley
- 03/17/23 Gordon Haskett
- Gordon Haskett downgrades Dollar General with 'more questions than answers'
- 03/17/23 Loop Capital
- Honest Company price target lowered to $2 from $3 at Loop Capital
- 03/16/23 DA Davidson
- BRC Inc. price target lowered to $10 from $12 at DA Davidson
- 03/07/23 Morgan Stanley
- Survey points to Walmart+ nearing 18.5M members, says Morgan Stanley
- 03/22/23 Barclays
- Charles Schwab price target lowered to $61 from $79 at Barclays
- 03/15/23 Credit Suisse
- Charles Schwab upgraded to Outperform from Neutral at Credit Suisse
- 03/14/23 JPMorgan
- Schwab funding concerns 'significantly de-risked,' says JPMorgan
- 03/14/23 Piper Sandler
- Charles Schwab price target lowered to $95 from $100 at Piper Sandler
- 03/21/23 Morgan Stanley
- BP price target lowered to 605 GBp from 660 GBp at Morgan Stanley
- 02/24/23 JPMorgan
- BP price target raised to 585 GBp from 540 GBp at JPMorgan
- 02/23/23 Berenberg
- BP downgraded to Hold from Buy at Berenberg
- 02/17/23 BMO Capital
- TravelCenters price target raised to $86 from $60 at BMO Capital
- 02/15/23 BMO Capital
- Starbucks price target raised to $125 from $120 at BMO Capital
- 02/06/23 Argus
- Starbucks facing weaker China comps, rising labor costs, says Argus
- 02/03/23 RBC Capital
- Starbucks price target lowered to $109 from $112 at RBC Capital
- 02/03/23 Cowen
- Starbucks price target raised to $116 from $112 at Cowen
- 03/22/23 Morgan Stanley
- Rivian now trading just below cash value, says Morgan Stanley
- 03/21/23 Morgan Stanley
- EV price cuts 'not a fad, but a trend,' says Morgan Stanley
- 03/20/23 Morgan Stanley
- XPeng price target raised to $12.50 from $12 at Morgan Stanley
- 03/20/23 Morgan Stanley
- Li Auto price target raised to $30 from $23 at Morgan Stanley
- 10:37 Today Raymond James
- Raymond James ups Regeneron to Market Perform as few downside catalysts remain
- 10:33 Today Raymond James
- Regeneron upgraded to Market Perform from Underperform at Raymond James
- 03/20/23 RBC Capital
- Regeneron price target lowered to $802 from $806 at RBC Capital
- 03/17/23 Morgan Stanley
- Regeneron pressure from CMS draft a buying opportunity, says Morgan Stanley
- 03/14/23 Jefferies
- Provention Bio downgraded to Hold from Buy at Jefferies
- 02/08/23 Morgan Stanley
- Regeneron named 'Catalyst Driven Idea' at Morgan Stanley ahead of COPD data
- 01/31/23 Berenberg
- Sanofi price target raised to EUR 100 from EUR 91 at Berenberg
- 12/21/22 Barclays
- Sanofi, Pfizer settled first California Zantac bellwether case, says Barclays
- 06:25 Today UBS
- On Holding price target raised to $39 from $27 at UBS
- 03/22/23 Baird
- On Holding price target raised to $33 from $31 at Baird
- 03/21/23 UBS
- On Holding Q4 results were 'exceptional', says UBS
- 03/21/23 Credit Suisse
- On Holding price target raised to $33 from $28 at Credit Suisse
- 03/15/23 BofA
- First BanCorp removed from 'Endeavor List' at BofA, four stocks added
- 02/16/23 Lake Street
- Trupanion price target raised to $75 from $67 at Lake Street
- 02/16/23 Canaccord
- Trupanion price target raised to $72 from $66 at Canaccord
- 12/20/22 Piper Sandler
- Trupanion price target raised to $53 from $46 at Piper Sandler
- 10/19/22 H.C. Wainwright
- Uranium Energy price target raised to $8.25 from $7.25 at H.C. Wainwright
- 10/13/22 Canaccord
- Uranium Energy price target raised to $6.50 from $6.00 at Canaccord
- 06/15/22 Canaccord
- Uranium Energy price target raised to $6 from $5.50 at Canaccord
- 06/13/22 Canaccord
- Uranium Energy upgraded to Speculative Buy after deal at Canaccord
- 08:43 Today Truist
- Comerica price target lowered to $54 from $78 at Truist
- 03/16/23 Citi
- Citi refreshes North America Focus List with five changes
- 03/15/23 UBS
- Comerica initiated with a Buy at UBS
- 03/13/23 Odeon Capital
- Comerica downgraded to Hold from Buy at Odeon Capital
- 03/16/23 Citi
- Accenture price target lowered to $300 from $305 at Citi
- 03/15/23 Morgan Stanley
- Accenture price target lowered to $325 from $340 at Morgan Stanley
- 01/30/23 Wells Fargo
- Accenture initiated with an Equal Weight at Wells Fargo
- 12/20/22 Cowen
- Accenture price target raised to $300 from $295 at Cowen
- 11/29/22 Benchmark
- Steelcase downgraded to Hold at Benchmark amid demand 'soft patch'
- 11/29/22 Benchmark
- Steelcase downgraded to Hold from Buy at Benchmark
- 10/04/22 Sidoti
- Steelcase upgraded to Buy from Neutral at Sidoti
- 09/23/22 Benchmark
- Steelcase price target lowered to $12 from $16 at Benchmark
- 09:19 Today RBC Capital
- KB Home price target raised to $37 from $34 at RBC Capital
- 06:26 Today UBS
- KB Home price target raised to $48 from $45 at UBS
- 03/06/23 JPMorgan
- KB Home downgraded to Underweight from Overweight at JPMorgan
- 01/13/23 BTIG
- KB Home earnings miss driven by fewer deliveries, says BTIG
- 03/17/23 CICC
- FactSet initiated with an Outperform at CICC
- 01/12/23 Credit Suisse
- FactSet upgraded to Outperform from Neutral at Credit Suisse
- 12/21/22 Deutsche Bank
- FactSet price target lowered to $477 from $493 at Deutsche Bank
- 12/21/22 UBS
- FactSet price target raised to $425 from $399 at UBS
- 02/21/23
- Coinbase reports Q4 EPS ($2.46) vs. $3.32 y/y
- 02/21/23
- Notable companies reporting after market close
- 01/10/23
- Coinbase sees FY22 adjusted EBITDA within negative $500M loss 'guardrail'
- 12/07/22
- Coinbase CEO tells Bloomberg 2022 revenue seen down 50% or more
- 02/02/23
- Ford sees FY23 adjusted EBIT of $9B-$11B
- 02/02/23
- Ford reports Q4 adjusted EPS 51c, consensus 62c
- 02/02/23
- Notable companies reporting after market close
- 10/26/22
- Ford reports Q3 adjusted EPS 39c, consensus 27c
- 07:04 Today
- Darden revises FY23 EPS view to $7.85-$8.00 from $7.60-$8.00, consensus $7.85
- 07:00 Today
- Darden reports Q3 EPS $2.34, consensus $2.25
- 03/22/23
- Notable companies reporting before tomorrow's open
- 03/22/23
- Notable companies reporting before tomorrow's open
- 02/23/23
- Block reports Q4 EPS 22c, consensus 30c
- 02/23/23
- Notable companies reporting after market close
- 11/03/22
- Block reports Q3 adjusted EPS 42c, consensus 23c
- 11/03/22
- Notable companies reporting after market close
- 07:20 Today
- General Mills raises FY23 adjusted EPS view to up 8%-9% from up 7%-8%
- 07:18 Today
- General Mills reports Q3 adjusted EPS 97c, consensus 92c
- 03/22/23
- Notable companies reporting before tomorrow's open
- 03/22/23
- Notable companies reporting before tomorrow's open
- 01/09/23
- Accolade guides initial FY24 revenue around $410M, consensus $405.4M
- 01/09/23
- Accolade narrows FY23 revenue view to $361M-$365M, consensus $359.2M
- 01/09/23
- Accolade sees Q4 revenue $97M-$101M, consensus $101.7M
- 01/09/23
- Accolade reports Q3 EPS (56c), consensus (62c)
- 03/22/23
- Chewy sees FY23 revenue $11.1B-$11.3B , consensus $11.13B
- 03/22/23
- Chewy sees Q1 revenue $2.72B-$2.74B, consensus $2.67B
- 03/22/23
- Chewy reports Q4 adjusted EPS 16c, consensus (11c)
- 03/22/23
- Notable companies reporting after market close
- 03/02/23
- Samsara sees FY24 EPS (7c) to (5c), consensus (15c)
- 03/02/23
- Samsara sees Q1 EPS (6c) to (5c), consensus (5c)
- 03/02/23
- Samsara reports Q4 EPS (2c), consensus (5c)
- 12/01/22
- Samsara raises FY23 EPS view to (17c)-(16c) from (23c)-(21c), consensus (21c)
- 02/06/23
- BellRing Brands backs FY23 revenue view $1.56B-$1.64B, consensus $1.59B
- 02/06/23
- BellRing Brands reports Q1 adjusted EPS 33c, consensus 27c
- 11/17/22
- BellRing Brands sees FY23 revenue $1.56B-$1.64B, consensus $1.59B
- 11/17/22
- BellRing Brands reports Q4 adjusted EPS 31c, consensus 29c
- 02/21/23
- Walmart sees FY24 adjusted EPS $5.90-$6.05, consensus $6.50
- 02/21/23
- Walmart sees Q1 adjusted EPS $1.25-$1.30, consensus $1.36
- 02/21/23
- Walmart reports Q4 adjusted EPS $1.71, consensus $1.51
- 11/15/22
- Walmart raises FY23 adjusted EPS view to down 5%-6% from down 9%-11%
- 01/18/23
- Charles Schwab reports Q4 adjusted EPS $1.07, consensus $1.09
- 01/17/23
- Notable companies reporting before tomorrow's open
- 01/17/23
- Notable companies reporting before tomorrow's open
- 10/27/22
- Charles Schwab backs 11%-13% year-over-year revenue growth outlook
- 02/07/23
- BP reports Q4 EPS $1.59, consensus $1.67
- 11/01/22
- BP reports Q3 EPS $2.59, consensus $1.94
- 02/02/23
- Starbucks reports Q1 EPS 75c, consensus 77c
- 02/02/23
- Notable companies reporting after market close
- 11/03/22
- Starbucks sees FY23 adjusted EPS growth at low end of 15%-20% range
- 11/03/22
- Starbucks reports Q4 adjusted EPS 81c, consensus 72c
- 03/02/23
- Aehr Test Systems reiterates annual guidance, comments on Tesla statements
- 01/25/23
- Tesla reports Q4 EPS $1.19, consensus $1.13
- 01/25/23
- Notable companies reporting after market close
- 10/19/22
- Tesla reports Q3 EPS $1.05, consensus 99c
- 02/03/23
- Regeneron reports Q4 adjusted EPS $12.56, consensus $10.03
- 02/02/23
- Notable companies reporting before tomorrow's open
- 02/02/23
- Notable companies reporting before tomorrow's open
- 01/09/23
- Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea
- 02/03/23
- Sanofi sees 2023 business EPS up at low single digit rate at CER
- 02/03/23
- Sanofi reports Q4 business EPS EUR 1.71, up 17.4% at CER
- 10/28/22
- Sanofi now sees 2022 business EPS growing 16% at CER
- 10/28/22
- Sanofi reports Q3 business EPS EUR 2.88, up 17.9% at CER
- 03/21/23
- On Holding sees FY23 revenue of 'at least' CHF 1.7B vs. CHF 1.22B last year
- 03/21/23
- On Holding reports Q4 EPS CHF0.02 vs. (CHF0.04) last year
- 11/16/22
- On Holding raises FY22 revenue view to CHF 1.125B from CHF 1.1B
- 11/16/22
- On Holding reports Q3 EPS CHF0.06 vs. CHF0.04 last year
- 02/16/23
- Trupanion sees FY23 revenue $1.32B-$1.64B, consensus $1.31B
- 02/16/23
- Trupanion sees Q1 revenue $249M-$253M, consensus $267.72M
- 02/15/23
- Trupanion reports Q4 EPS (23c), consensus (29c)
- 11/03/22
- Trupanion reports Q3 EPS (32c), consensus (28c)
- 01/19/23
- Comerica reports Q4 EPS $2.58, consensus $2.55
- 10/19/22
- Comerica reports Q3 EPS $2.60, consensus $2.57
- 06:47 Today
- Accenture sees Q3 revenue $16.1B-$16.7B, consensus $16.64B
- 06:46 Today
- Accenture raises FY23 EPS view to $11.41-$11.63 from $11.20-$11.52
- 06:44 Today
- Accenture reports Q2 adjusted EPS $2.69, consensus $2.50
- 12/16/22
- Accenture sees Q2 revenue $15.2B-$15.75B, consensus $15.59B
- 03/22/23
- Steelcase sees FY24 EPS 55c-75c, consensus 59c
- 03/22/23
- Steelcase sees Q1 EPS (2c)-2c, consensus (7c)
- 03/22/23
- Steelcase reports Q4 EPS 13c, consensus 11c
- 12/19/22
- Steelcase sees Q4 adjusted EPS 11c-15c, consensus 12c
- 03/22/23
- KB Home reports Q1 EPS $1.45, consensus $1.14
- 03/22/23
- Notable companies reporting after market close
- 01/11/23
- KB Home reports Q4 EPS $2.47, consensus $2.87
- 07:05 Today
- FactSet sees 2023 adjusted EPS $14.50-$14.90, consensus $14.89
- 07:03 Today
- FactSet reports Q2 adjusted EPS $3.80, consensus $3.69
- 12/20/22
- FactSet reaffirms 2023 adjusted EPS view $14.50-$14.90, consensus $14.79
- 12/20/22
- FactSet reports Q1 adjusted EPS $3.99, consensus $3.61
|
